Product Program year 2022 Source: CMS Open Payments

Flumist

Biological Respiratory

NDC 66019-110-10

Open in the dashboard

General payments

$2,238,119

633 payments

Research payments

$0

0 payments

Through program year 2022, $2,238,119 in general payments and $0 in research payments were reported against Flumist (Respiratory).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

1 row
Year Kind Amount Payments
2022 General $2,238,119 633

Breakdown

Who paid General payments · program year 2022
  1. AstraZeneca Pharmaceuticals LP $2,238,119 633 payments
Top recipients General payments · program year 2022
  1. Univ Of Mi Hospitals & Hlth Ctrs Teaching hospital · MI $2,217,779 99% · 1 payment
  2. Childrens Hospital Colorado Teaching hospital · CO $3,750 <1% · 2 payments
  3. Ravi Jhaveri Pediatric Infectious Diseases · Chicago, IL $2,100 <1% · 2 payments
  4. Myron Levin Pediatric Infectious Diseases · Aurora, CO $1,611 <1% · 1 payment
  5. Janet Englund Pediatric Infectious Diseases · Seattle, WA $1,600 <1% · 1 payment

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2022.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2022
  1. Pediatrics $6,899 42% · 317 practitioners
  2. Pediatric Infectious Diseases Pediatrics $5,311 32% · 3 practitioners
  3. Nurse Practitioner, Pediatrics Nurse Practitioner $816 5% · 39 practitioners
  4. Nephrology Internal Medicine $531 3% · 19 practitioners
  5. Adolescent Medicine Pediatrics $393 2% · 16 practitioners

The top 5 of 34 specialties; each share is of general payments naming this product to practitioners with a specialty in 2022. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2022
  1. Michigan $2,218,001 99% · 18 recipients
  2. Colorado $5,525 <1% · 10 recipients
  3. Illinois $2,529 <1% · 15 recipients
  4. Washington $1,613 <1% · 2 recipients
  5. Massachusetts $1,127 <1% · 40 recipients

The top 5 of 32 states; each share is of general payments naming this product in 2022 where a state was reported.

The top 25 states, free in the app

633 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2022

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record